Recombinant DNA Constructs for High-Yield RNA Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The high cost of RNA synthesis hinders the widespread use and development of RNA products in agricultural and biopharmaceutical applications, such as RNA interference for pest control and mRNA vaccines, due to the need for cost-effective synthesis processes.

Innovation Solution

The development of recombinant DNA nucleic acid constructs with specific expression cassette designs, including promoters, transcription sequences, and terminators, to enhance the expression of RNA molecules, such as double-stranded RNA, using cell-free and in vitro transcription reactions, which improve yield and efficiency.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If traditional RNA synthesis methods are used, then RNA products can be produced, but the cost is high which hinders widespread use

Engineering Contradiction:
Improvecost-effectivenessVSAvoidRNA yield
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The patent divides the RNA synthesis process into two separate expression cassettes: one for the sense strand and one for the antisense strand. This segmentation allows independent optimization of each strand's transcription efficiency and enables cost-effective production while maintaining high RNA yields through coordinated expression from both cassettes.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent optimizes transcription parameters by selecting specific promoter types (bacteriophage T7, T3, or T5 promoters) and configuring expression cassettes with specific orientations (same direction or opposition directions). These parameter changes enable enhanced transcription efficiency and cost-effective RNA production while achieving high yields.

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If RNA synthesis cost is reduced, then widespread use is enabled, but synthesis efficiency and yield must be maintained

Engineering Contradiction:
Improvesynthesis costVSAvoidRNA expression efficiency
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent incorporates preliminary design elements into the expression cassettes, including proper promoter selection (T7, T3, or T5), orientation configuration (same or opposition directions), and terminator sequences. These preliminary actions ensure reliable and efficient RNA expression before the actual synthesis process, enabling cost reduction without sacrificing reliability.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses DNA templates that can be replicated and reused multiple times to produce RNA products. By creating stable DNA constructs with optimized expression cassettes, the system enables cost-effective production through repeated transcription from the same template, maintaining reliability while reducing per-unit synthesis costs.

Inventive Principle:
Principle #26Copying

3Productivity

If expression cassettes are designed for high yield, then RNA production increases, but construct complexity increases

Engineering Contradiction:
ImproveRNA yieldVSAvoidconstruct design
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent creates universal expression cassette designs that can be applied to produce different RNA products. The same cassette structure with selectable promoters (T7, T3, T5) and orientation options can be used for various RNA sequences, achieving high yields without proportionally increasing construct complexity through standardization and reusability.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These constructs enable cost-effective and high-yield production of RNA products, facilitating their broader application in agriculture and biopharmaceuticals by optimizing transcription processes and increasing RNA titers.

Implementation Method 1

a first expression cassette comprising a promoter operably linked to an initial transcription sequence (ITS) upstream of a nucleotide sequence encoding a sense strand of a double-stranded RNA (dsRNA)

Methodology Applied
Scientific EffectTranscription:

Data Source

PatentUS20220411792A1Nucleic acid compositions
Publication Date: 2022.12.29 GREENLIGHT BIOSCIENCES INC
  • US20220411792A1 patent drawing
  • US20220411792A1 patent drawing
  • US20220411792A1 patent drawing

AI summary

Provided herein, in some aspects, are compositions of nucleic acids comprising an initial transcribed sequence and unique nucleic acid designs for high-yield and cost-effective production of ribonucleic acids.